CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 132 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2021. The put-call ratio across all filers is 1.14 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $5,593,000 | -62.9% | 198,983 | -64.4% | 0.62% | -59.2% |
| Q2 2022 | $15,061,000 | -29.6% | 558,636 | -11.1% | 1.51% | +2.6% |
| Q1 2022 | $21,402,000 | +14.3% | 628,356 | +29.7% | 1.47% | +30.6% |
| Q4 2021 | $18,719,000 | -28.4% | 484,453 | 0.0% | 1.13% | -3.8% |
| Q3 2021 | $26,156,000 | -19.3% | 484,453 | -50.0% | 1.17% | -16.3% |
| Q2 2021 | $32,400,000 | +21.7% | 968,906 | -25.0% | 1.40% | +50.1% |
| Q1 2021 | $26,613,000 | +17.6% | 1,291,875 | 0.0% | 0.94% | -7.4% |
| Q4 2020 | $22,634,000 | -11.4% | 1,291,875 | -25.0% | 1.01% | -31.6% |
| Q3 2020 | $25,545,000 | +22.8% | 1,722,500 | +7.7% | 1.48% | -1.0% |
| Q2 2020 | $20,800,000 | – | 1,600,000 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 3,200,000 | $88,064,000 | 14.40% |
| Octagon Capital Advisors LP | 759,898 | $20,912,393 | 3.21% |
| TSP Capital Management Group, LLC | 251,695 | $6,926,645 | 2.67% |
| 5AM Venture Management, LLC | 310,270 | $8,538,630 | 2.46% |
| COMMODORE CAPITAL LP | 706,665 | $19,447,421 | 2.27% |
| ACUTA CAPITAL PARTNERS, LLC | 122,341 | $3,366,824 | 2.26% |
| Redmile Group, LLC | 1,635,938 | $45,021,014 | 2.14% |
| RTW INVESTMENTS, LP | 3,463,201 | $95,307,292 | 2.01% |
| Eversept Partners, LP | 588,143 | $16,185,695 | 1.37% |
| Affinity Asset Advisors, LLC | 150,000 | $4,128,000 | 1.16% |